Neuroscience

AI in Telehealth & Telemedicine Market worth $27.14 Billion by 2030 with 36.4% CAGR | MarketsandMarkets™AI in Telehealth & Telemedicine Market worth $27.14 Billion by 2030 with 36.4% CAGR | MarketsandMarkets™

AI in Telehealth & Telemedicine Market worth $27.14 Billion by 2030 with 36.4% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., July 29, 2025 /PRNewswire/ -- The global AI in Telehealth & Telemedicine Market, valued at US$2.85 billion…

8 hours ago
Creyos Featured in Alzheimer’s Research at AAIC 2025Creyos Featured in Alzheimer’s Research at AAIC 2025

Creyos Featured in Alzheimer’s Research at AAIC 2025

Findings from Western University, QIMR Berghofer, and Rotman Research Institute underscore the power of Creyos in detecting early risk, validating digital…

8 hours ago
Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s DiseaseTherini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

Therini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease

- Pioneering approach to halting the chronic neuroinflammation responsible for neurodegeneration- Trial to assess safety, PK and detect early signs…

11 hours ago
ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International ConferenceProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference

ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference

Presentation to highlight the Company’s proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 Posters highlighting PRECISE-AD, the Company’s Phase 1b…

11 hours ago
Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic StrokePharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke

Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke

The Phase 3 clinical trial of sovateltide, RESPECT-ETB, is expected to enroll over 500 patients with a primary endpoint of…

11 hours ago
Red Light Holland Reports 2025 Audited Year-End Results – Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D ExpansionRed Light Holland Reports 2025 Audited Year-End Results – Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion

Red Light Holland Reports 2025 Audited Year-End Results – Demonstrates Continued Fiscal Discipline, Strategic Growth, and Psilocybin R&D Expansion

Toronto, Ontario--(Newsfile Corp. - July 29, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

12 hours ago
$10 Million Philanthropic Donation Launches Research Effort into Root Causes of Stuttering$10 Million Philanthropic Donation Launches Research Effort into Root Causes of Stuttering

$10 Million Philanthropic Donation Launches Research Effort into Root Causes of Stuttering

COSTA MESA, Calif., July 28, 2025 /PRNewswire/ -- The newly founded Stuttering Treatment and Research Society (STARS) announced it is the…

1 day ago
Anywhere powered by Linus Health™ Expands Equitable Access to Early Detection of Cognitive ImpairmentAnywhere powered by Linus Health™ Expands Equitable Access to Early Detection of Cognitive Impairment

Anywhere powered by Linus Health™ Expands Equitable Access to Early Detection of Cognitive Impairment

Fueled by successful community and clinical screenings, Linus Health brings its AI-powered remote cognitive assessment platform to payers, pharma, wellness…

1 day ago
AI Meets Brain Health: League and Linus Health Collaborate to Expand Health Plan PlatformsAI Meets Brain Health: League and Linus Health Collaborate to Expand Health Plan Platforms

AI Meets Brain Health: League and Linus Health Collaborate to Expand Health Plan Platforms

Bringing early detection of cognitive impairment to the forefront of health plan CX — empowering personalized, proactive brain health BOSTON…

1 day ago
Cumulus Neuroscience Presents Data at AAIC 2025 Annual Meeting and Technology and Dementia PreconferenceCumulus Neuroscience Presents Data at AAIC 2025 Annual Meeting and Technology and Dementia Preconference

Cumulus Neuroscience Presents Data at AAIC 2025 Annual Meeting and Technology and Dementia Preconference

Analysis of first-in-class CNS-101 study validates that at-home endpoints showed greater separation with Alzheimer's pathology (pTau217) than the benchmark endpoint…

1 day ago